Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Lysosome-Dependent Activation of Human Dendritic Cells by the Vaccine Adjuvant QS-21
Iain Welsby, Sophie Detienne, Francisca N’Kuli, et al.
Frontiers in Immunology (2017) Vol. 7
Open Access | Times Cited: 79

Showing 1-25 of 79 citing articles:

Emerging concepts in the science of vaccine adjuvants
Bali Pulendran, Prabhu S. Arunachalam, Derek T. O’Hagan
Nature Reviews Drug Discovery (2021) Vol. 20, Iss. 6, pp. 454-475
Open Access | Times Cited: 960
Correlates of adjuvanticity: A review on adjuvants in licensed vaccines
Giuseppe Del Giudice, Rino Rappuoli, Arnaud M. Didierlaurent
Seminars in Immunology (2018) Vol. 39, pp. 14-21
Open Access | Times Cited: 547
Adjuvants Enhancing Cross-Presentation by Dendritic Cells: The Key to More Effective Vaccines?
Nataschja I. Ho, Lisa G. M. Huis in ’t Veld, Tonke K. Raaijmakers, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 187
Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action
Carlo Pifferi, Roberto González Fuentes, Alberto Fernández‐Tejada
Nature Reviews Chemistry (2021) Vol. 5, Iss. 3, pp. 197-216
Open Access | Times Cited: 181
An Overview of Vaccine Adjuvants: Current Evidence and Future Perspectives
Alessio Facciolà, Giuseppa Visalli, A. Laganà, et al.
Vaccines (2022) Vol. 10, Iss. 5, pp. 819-819
Open Access | Times Cited: 160
New-age vaccine adjuvants, their development, and future perspective
Shailendra Kumar Verma, Pooja Mahajan, Nikhlesh K. Singh, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 91
Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases
Jingxing Yang, Jen‐Chih Tseng, Guann‐Yi Yu, et al.
Pharmaceutics (2022) Vol. 14, Iss. 2, pp. 423-423
Open Access | Times Cited: 81
The Matrix-M™ adjuvant: A critical component of vaccines for the 21 st century
Linda Stertman, Anna-Karin E. Palm, Behdad Zarnegar, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 55
Vaccine adjuvants: Tailoring innate recognition to send the right message
Ed C. Lavelle, Craig P. McEntee
Immunity (2024) Vol. 57, Iss. 4, pp. 772-789
Open Access | Times Cited: 17
Updated insights into the mechanism of action and clinical profile of the immunoadjuvant QS-21: A review
Marie‐Aleth Lacaille‐Dubois
Phytomedicine (2019) Vol. 60, pp. 152905-152905
Open Access | Times Cited: 127
Different Adjuvants Induce Common Innate Pathways That Are Associated with Enhanced Adaptive Responses against a Model Antigen in Humans
Wivine Burny, Andrea Callegaro, Viviane Bechtold, et al.
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 126
Better Adjuvants for Better Vaccines: Progress in Adjuvant Delivery Systems, Modifications, and Adjuvant–Antigen Codelivery
Zhibiao Wang, Jing Xu
Vaccines (2020) Vol. 8, Iss. 1, pp. 128-128
Open Access | Times Cited: 126
Saponins from Quillaja saponaria and Quillaja brasiliensis: Particular Chemical Characteristics and Biological Activities
Juliane Deise Fleck, Andresa Heemann Betti, Francini Pereira da Silva, et al.
Molecules (2019) Vol. 24, Iss. 1, pp. 171-171
Open Access | Times Cited: 119
Lysosomal Cathepsin Release Is Required for NLRP3-Inflammasome Activation by Mycobacterium tuberculosis in Infected Macrophages
Eduardo P. Amaral, Nicolas Riteau, Mahtab Moayeri, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 103
Towards an evidence based approach for the development of adjuvanted vaccines
Derek T. O’Hagan, Leonard R. Friedland, Emmanuel Hanon, et al.
Current Opinion in Immunology (2017) Vol. 47, pp. 93-102
Open Access | Times Cited: 99
Selection of adjuvants for vaccines targeting specific pathogens
Indranil Sarkar, Ravendra Garg, Sylvia van Drunen Littel‐van den Hurk
Expert Review of Vaccines (2019) Vol. 18, Iss. 5, pp. 505-521
Open Access | Times Cited: 94
Elucidating the Mechanisms of Action of Saponin-Derived Adjuvants
Dante J. Marciani
Trends in Pharmacological Sciences (2018) Vol. 39, Iss. 6, pp. 573-585
Closed Access | Times Cited: 92
Development of adjuvanted recombinant zoster vaccine and its implications for shingles prevention
Nicolas Lecrenier, Pierre Beukelaers, Rómulo E. Colindres, et al.
Expert Review of Vaccines (2018) Vol. 17, Iss. 7, pp. 619-634
Open Access | Times Cited: 92
Natural and Synthetic Saponins as Vaccine Adjuvants
Pengfei Wang
Vaccines (2021) Vol. 9, Iss. 3, pp. 222-222
Open Access | Times Cited: 92
Vaccines to Prevent Infectious Diseases in the Older Population: Immunological Challenges and Future Perspectives
Angelika Wagner, Birgit Weinberger
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 85
SARS-CoV-2 ferritin nanoparticle vaccine induces robust innate immune activity driving polyfunctional spike-specific T cell responses
Joshua M. Carmen, Shikha Shrivastava, Zhongyan Lu, et al.
npj Vaccines (2021) Vol. 6, Iss. 1
Open Access | Times Cited: 66
Vaccine adjuvants to engage the cross-presentation pathway
Woo‐Jong Lee, M. Suresh
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 63
Exploration of Pattern Recognition Receptor Agonists as Candidate Adjuvants
Guang Han Ong, Benedict Shi Xiang Lian, Takumi Kawasaki, et al.
Frontiers in Cellular and Infection Microbiology (2021) Vol. 11
Open Access | Times Cited: 61
Immunostimulatory Polymers as Adjuvants, Immunotherapies, and Delivery Systems
Adam M. Weiss, Samir Hossainy, Stuart J. Rowan, et al.
Macromolecules (2022) Vol. 55, Iss. 16, pp. 6913-6937
Open Access | Times Cited: 45
Novel adjuvants in allergen-specific immunotherapy: where do we stand?
Yen‐Ju Lin, Jennifer Zimmermann, Stefan Schülke
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 12
Page 1 - Next Page

Scroll to top